Case number 1:23-cv-00665
Bayer Pharma AG et al v. Macleods Pharmaceuticals Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 25, 2024 | 17 | STIPULATION of Dismissal between Plaintiffs and Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc. with prejudice - by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Smith, Rodger) Modified on 1/25/2024 (nms). (Entered: 01/25/2024) (2) |
| Jan 25, 2024 | 18 | SO ORDERED Granting (D.I. 210 in 21-md-3017-RGA-LDH; D.I. 17 in 23-cv-665-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.. Signed by Judge Richard G. Andrews on 1/25/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00665-RGA(nms) (Entered: 01/25/2024) (2) |
| Jan 25, 2024 | 19 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (Attachments: # 1 Order)(nms) (Entered: 01/25/2024) (0) |
| Nov 30, 2023 | 16 | MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth and Teresa M. Summers of Wiley Rein, L.L.P. - filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Attachments: # 1 Certification of A. Neal Seth, # 2 Certification of Teresa M. Summers, # 3 Text of Proposed Order)(Seaman, John) (Entered: 11/30/2023) (0) |
| Sep 5, 2023 | 15 | Answer to Counterclaims of Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc., filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/5/2023 (nms). (Entered: 09/05/2023) (7) |
| Aug 15, 2023 | 10 | NOTICE of Appearance by John M. Seaman on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Seaman, John) (Entered: 08/15/2023) (1) |
| Aug 15, 2023 | 11 | NOTICE of Appearance by April M Ferraro on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Ferraro, April) (Entered: 08/15/2023) (1) |
| Aug 15, 2023 | 12 | NOTICE of Appearance by G. Mason Thomson on behalf of Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd. (Thomson, G.) (Entered: 08/15/2023) (1) |
| Aug 15, 2023 | 13 | ANSWER to 1 Complaint, and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Macleods Pharmaceuticals Ltd., Macleods Pharma USA, Inc..(Thomson, G.) Modified on 8/16/2023 (nms). (Entered: 08/15/2023) (22) |
| Aug 15, 2023 | 14 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd.. (Thomson, G.) (Entered: 08/15/2023) (2) |
| Jul 14, 2023 | 9 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Macleaods Pharmaceuticals Ltd. on July 12, 2023, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 07/14/2023) (10) |
| Jul 12, 2023 | 8 | SUMMONS Returned Executed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..Macleods Pharma USA, Inc. served on 7/12/2023, answer due 8/2/2023. (Fahnestock, Derek) (Entered: 07/12/2023) (3) |
| Jun 21, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 06/21/2023) (0) |
| Jun 16, 2023 | 1 | COMPLAINT filed against Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. (Filing fee $ 402, receipt number ADEDC-4160634.) - filed by Bayer Pharma AG, and Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mkr) (Entered: 06/16/2023) (Main Document) (12) |
| Jun 16, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mkr) (Entered: 06/16/2023) (3) |
| Jun 16, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 5/3/2023. Date of Expiration of Patent: U.S. Patent 10,828,310 expires January 31, 2039, with pediatric exclusivity to July 31, 2039. U.S. Patent 7,157,456 expires August 28, 2024, with pediatric exclusivity to February 28, 2025. (mkr) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (mkr) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (mkr) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (mkr) (Entered: 06/16/2023) (1) |
| Jun 16, 2023 | 7 | Summonses Issued (please complete the top portion of the form and print out for use/service). (mkr) (Entered: 06/16/2023) (2) |
| Jun 16, 2023 | 1 | COMPLAINT filed against Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. (Filing fee $ 402, receipt number ADEDC-4160634.) - filed by Bayer Pharma AG, and Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mkr) (Entered: 06/16/2023) (Exhibit A) (27) |
| Jun 16, 2023 | 1 | COMPLAINT filed against Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. (Filing fee $ 402, receipt number ADEDC-4160634.) - filed by Bayer Pharma AG, and Janssen Pharmaceuticals, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(mkr) (Entered: 06/16/2023) (Civil Cover Sheet) (2) |
